Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
3(8%)
Results Posted
6%(1 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_1
2
5%
Ph phase_2
7
18%
Ph phase_4
4
11%
Ph phase_3
5
13%
Ph early_phase_1
1
3%
Ph not_applicable
18
47%

Phase Distribution

3

Early Stage

7

Mid Stage

9

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
1(2.7%)
Phase 1Safety & dosage
2(5.4%)
Phase 2Efficacy & side effects
7(18.9%)
Phase 3Large-scale testing
5(13.5%)
Phase 4Post-market surveillance
4(10.8%)
N/ANon-phased studies
18(48.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

16 of 18 finished

Non-Completion Rate

11.1%

2 ended early

Currently Active

3

trials recruiting

Total Trials

38

all time

Status Distribution
Active(8)
Completed(16)
Terminated(2)
Other(12)

Detailed Status

Completed16
unknown12
Not yet recruiting5
Recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
38
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.7%)
Phase 12 (5.4%)
Phase 27 (18.9%)
Phase 35 (13.5%)
Phase 44 (10.8%)
N/A18 (48.6%)

Trials by Status

completed1642%
terminated25%
recruiting38%
not_yet_recruiting513%
unknown1232%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT07585396Phase 2

Inositol in Letrozol Resistant PCOS Women

Completed
NCT07629895Not Applicable

Myo-Inositol Alone Versus Myo-Inositol Plus Alpha-Lactalbumin in Women With Polycystic Ovary Syndrome

Not Yet Recruiting
NCT07630779Phase 3

Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients

Recruiting
NCT07459595Phase 1

Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

Not Yet Recruiting
NCT07387679Not Applicable

Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity

Completed
NCT07380841Not Applicable

Metformin vs Inositol vs Diet vs Combination Therapy in PCOS

Completed
NCT07323589Phase 3

Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

Completed
NCT07266259Not Applicable

Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women

Recruiting
NCT07058675Not Applicable

Myoinositol vs. Metformin for Polycystic Ovarian Syndrome (PCOS): Impact on Metabolic Health and Fertility

Completed
NCT04576546Not Applicable

Inositols and FSH in IVF

Completed
NCT06575868Not Applicable

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

Recruiting
NCT06840613Not Applicable

Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus

Not Yet Recruiting
NCT03283813Phase 4

ZIMBA: Clinical Trial in Paediatric Obesity

Completed
NCT06405204Phase 3

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Not Yet Recruiting
NCT06405243Phase 3

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Not Yet Recruiting
NCT04892186Not Applicable

Effects of Myo-inositol in Women With Polycystic Ovary Syndrome

Completed
NCT03177122Phase 4

Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology

Unknown
NCT05900661Phase 2

The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

Unknown
NCT05678114Not Applicable

Inositol Treatment in Different Type of PCOS Phenotype

Completed
NCT04306692Phase 4

Myo-inositol Versus Clomiphene Citrate in PCOS

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
38